Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76726 - 76750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamoxifen	Approved Investigational	CD36	948	downregulated	Tamoxifen results in decreased expression of CD36 mRNA	7q21.11	A24110
Tamoxifen	Approved Investigational	CD6	923	downregulated	Tamoxifen results in decreased expression of CD6 mRNA	11q12.2	A24383
Tamoxifen	Approved Investigational	CDK1	983	downregulated	Tamoxifen results in decreased expression of CDK1 mRNA	10q21.2	A3616
Tamoxifen	Approved Investigational	CDK2	1017	upregulated	Tamoxifen results in increased expression of CDK2 mRNA	12q13.2	A22730
Tamoxifen	Approved Investigational	CDKN1A	1026	upregulated	Tamoxifen results in increased expression of CDKN1A mRNA	6p21.2	A21195
Tamoxifen	Approved Investigational	CEBPB	1051	upregulated	Tamoxifen results in increased expression of CEBPB mRNA	20q13.13	A3616
Tamoxifen	Approved Investigational	CECR6	27439	upregulated	Tamoxifen results in increased expression of CECR6 mRNA	22q11.1	A21164
Tamoxifen	Approved Investigational	COL11A2	1302	upregulated	Tamoxifen results in increased expression of COL11A2 mRNA	6p21.32	A24383
Tamoxifen	Approved Investigational	CRYM	1428	downregulated	Tamoxifen results in decreased expression of CRYM mRNA	16p12.2	A24383
Tamoxifen	Approved Investigational	CSF3	1440	downregulated	Tamoxifen results in decreased expression of CSF3 mRNA	17q21.1	A21168
Tamoxifen	Approved Investigational	CSPG4	1464	upregulated	Tamoxifen results in increased expression of CSPG4 mRNA	15q24.2	A24383
Tamoxifen	Approved Investigational	CTBS	1486	upregulated	Tamoxifen results in increased expression of CTBS mRNA	1p22.3	A3616
Tamoxifen	Approved Investigational	CTRL	1506	downregulated	Tamoxifen results in decreased expression of CTRL mRNA	16q22.1	A24383
Tamoxifen	Approved Investigational	CXADR	1525	upregulated	Tamoxifen results in increased expression of CXADR mRNA	21q21.1	A21218
Tamoxifen	Approved Investigational	CXADR	1525	upregulated	Tamoxifen results in increased expression of CXADR mRNA alternative form	21q21.1	A21218
Tamoxifen	Approved Investigational	CXCL12	6387	downregulated	Tamoxifen results in decreased expression of CXCL12 mRNA	10q11.21	A21223
Tamoxifen	Approved Investigational	CXCL12	6387	upregulated	Tamoxifen results in increased expression of CXCL12 mRNA	10q11.21	A20996
Tamoxifen	Approved Investigational	CXCL3	2921	downregulated	Tamoxifen results in decreased expression of CXCL3 mRNA	4q13.3	A21168
Tamoxifen	Approved Investigational	CXCL8	3576	downregulated	Tamoxifen results in decreased expression of CXCL8 mRNA	4q13.3	A21168
Tamoxifen	Approved Investigational	CXCL8	3576	upregulated	Tamoxifen results in increased expression of CXCL8 mRNA	4q13.3	A3616
Tamoxifen	Approved Investigational	CXCR4	7852	downregulated	Tamoxifen results in decreased expression of CXCR4 mRNA	2q22.1	A24387
Tamoxifen	Approved Investigational	CYCS	54205	upregulated	Tamoxifen results in increased expression of CYCS mRNA	7p15.3	A21141
Tamoxifen	Approved Investigational	CYLC2	1539	upregulated	Tamoxifen results in increased expression of CYLC2 mRNA	9q31.1	A21112
Tamoxifen	Approved Investigational	CYP19A1	1588	upregulated	Tamoxifen analog results in increased expression of CYP19A1 mRNA	15q21.2	A20484
Tamoxifen	Approved Investigational	CYP19A1	1588	downregulated	Tamoxifen results in decreased expression of CYP19A1 mRNA	15q21.2	A23769 A21058

Displaying entries 76726 - 76750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability